Back
Crinetics Pharmaceuticals Vs. Biomea Fusion Industry Stock Comparison
Buy
68
CRNX
Crinetics Pharmaceuticals
Last Price:
59.10
Seasonality Move:
10.45%
Sell
5
BMEA
Biomea Fusion
Last Price:
8.86
Seasonality Move:
6.09%
Buy
68
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
- The current Crinetics Pharmaceuticals [CRNX] share price is $57.81. The Score for CRNX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- CRNX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Biomea Fusion (BMEA)
is a Sell
Is Biomea Fusion a Buy, Sell or Hold?
- The current Biomea Fusion [BMEA] share price is $8.91. The Score for BMEA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- BMEA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $57.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMEA Stock Price Chart
What is Biomea Fusion's stock price today?
-
The Biomea Fusion share price today is $8.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMEA is experiencing slight buying pressure.
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 59.55 | Buy |
| Chaikin Money Flow: | 308844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.77 - 58.39) | Buy |
| Bollinger Bands (100): | (47.89 - 55.75) | Buy |
BMEA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 37.8 | Sell |
| Chaikin Money Flow: | 202930 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.72 - 11.7) | Sell |
| Bollinger Bands (100): | (5.06 - 9.74) | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.8 | Buy |
| 20-day SMA: | 56.29 | Buy |
| 50-day SMA: | 53.83 | Buy |
| 200-day SMA: | 47.57 | Buy |
| 8-day EMA: | 56.99 | Buy |
| 20-day EMA: | 56.2 | Buy |
| 50-day EMA: | 54.33 | Buy |
| 200-day EMA: | 47.18 | Buy |
BMEA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.39 | Sell |
| 20-day SMA: | 10.85 | Sell |
| 50-day SMA: | 9.39 | Sell |
| 200-day SMA: | 10.66 | Sell |
| 8-day EMA: | 9.89 | Sell |
| 20-day EMA: | 10.31 | Sell |
| 50-day EMA: | 9.53 | Sell |
| 200-day EMA: | 10.26 | Sell |
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.21 per share.
Biomea Fusion Earnings Growth & BMEA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $0.80 per share.
Crinetics Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomea Fusion Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||